Titan Pharmaceuticals Inc (TTNP) — Cash Flow-to-Debt Ratio
Titan Pharmaceuticals Inc (TTNP) has a Cash Flow-to-Debt Ratio of -2.59x as of June 2025, meaning its operating cash flow of $-680.00K could theoretically repay -3% of its total liabilities ($263.00K) in one year. See TTNP cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Titan Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1995–2024)
Historical debt coverage capacity for Titan Pharmaceuticals Inc across 30 annual periods. Also explore TTNP shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Titan Pharmaceuticals Inc (1995–2024)
Year-by-year debt coverage analysis for Titan Pharmaceuticals Inc. For market capitalisation and broader financial context, see Titan Pharmaceuticals Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -8.03x | $-3.88 Million | $483.00K | ▼ -63.6% |
| 2023 | -4.91x | $-7.09 Million | $1.44 Million | ▼ -61.8% |
| 2022 | -3.04x | $-8.18 Million | $2.69 Million | ▼ -9.8% |
| 2021 | -2.77x | $-7.90 Million | $2.86 Million | ▲ +26.8% |
| 2020 | -3.78x | $-17.20 Million | $4.55 Million | ▼ -97.8% |
| 2019 | -1.91x | $-15.45 Million | $8.09 Million | ▼ -64.5% |
| 2018 | -1.16x | $-8.43 Million | $7.26 Million | ▲ +28.4% |
| 2017 | -1.62x | $-13.04 Million | $8.05 Million | ▼ -241.0% |
| 2016 | 1.15x | $6.29 Million | $5.48 Million | ▲ +196.9% |
| 2015 | -1.19x | $-7.47 Million | $6.30 Million | ▼ -147.4% |
| 2014 | -0.48x | $-5.87 Million | $12.24 Million | ▲ +38.1% |
| 2013 | -0.77x | $-9.80 Million | $12.66 Million | ▼ -2127.8% |
| 2012 | 0.04x | $1.83 Million | $47.95 Million | ▲ +108.0% |
| 2011 | -0.48x | $-14.48 Million | $30.30 Million | ▼ -10.9% |
| 2010 | -0.43x | $-4.66 Million | $10.80 Million | ▲ +68.6% |
| 2009 | -1.37x | $-5.41 Million | $3.93 Million | ▲ +78.8% |
| 2008 | -6.50x | $-25.34 Million | $3.90 Million | ▼ -82.1% |
| 2007 | -3.57x | $-15.19 Million | $4.26 Million | ▲ +10.3% |
| 2006 | -3.98x | $-13.50 Million | $3.39 Million | ▲ +45.6% |
| 2005 | -7.31x | $-22.92 Million | $3.14 Million | ▼ -12.2% |
| 2004 | -6.51x | $-23.91 Million | $3.67 Million | ▲ +17.7% |
| 2003 | -7.91x | $-26.44 Million | $3.34 Million | ▼ -6.6% |
| 2002 | -7.42x | $-29.29 Million | $3.94 Million | ▼ -211.5% |
| 2001 | -2.38x | $-13.74 Million | $5.76 Million | ▲ +55.4% |
| 2000 | -5.34x | $-13.16 Million | $2.46 Million | ▲ +6.8% |
| 1999 | -5.74x | $-10.90 Million | $1.90 Million | ▲ +29.9% |
| 1998 | -8.19x | $-13.10 Million | $1.60 Million | ▼ -930.3% |
| 1997 | 0.99x | $7.10 Million | $7.20 Million | ▲ +134.7% |
| 1996 | -2.84x | $-10.80 Million | $3.80 Million | ▼ -207.3% |
| 1995 | -0.92x | $-8.60 Million | $9.30 Million | — |